Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,174 | 45 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| MEDLINE INDUSTRIES LP | $152.87 | 1 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $147.87 | 6 | $0 (2024) |
| Janssen Biotech, Inc. | $147.71 | 7 | $0 (2024) |
| Lilly USA, LLC | $138.10 | 7 | $0 (2023) |
| Osiris Therapeutics Inc. | $118.07 | 2 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $95.14 | 5 | $0 (2022) |
| CONMED Corporation | $57.40 | 1 | $0 (2019) |
| GENZYME CORPORATION | $38.56 | 1 | $0 (2022) |
| Sun Pharmaceutical Industries Inc. | $36.27 | 2 | $0 (2023) |
| AbbVie Inc. | $32.77 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $90.42 | 4 | Janssen Biotech, Inc. ($38.57) |
| 2023 | $488.91 | 16 | MEDLINE INDUSTRIES LP ($152.87) |
| 2022 | $205.26 | 9 | Lilly USA, LLC ($84.29) |
| 2021 | $78.84 | 4 | Novartis Pharmaceuticals Corporation ($78.84) |
| 2020 | $17.11 | 1 | AbbVie Inc. ($17.11) |
| 2019 | $69.03 | 2 | CONMED Corporation ($57.40) |
| 2018 | $184.93 | 6 | Osiris Therapeutics Inc. ($118.07) |
| 2017 | $39.86 | 3 | AbbVie, Inc. ($15.66) |
All Payment Transactions
45 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $38.53 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/20/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Dermatology | ||||||
| 05/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Immunology | ||||||
| 04/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: Immunology | ||||||
| 12/07/2023 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Immunology | ||||||
| 09/15/2023 | MEDLINE INDUSTRIES LP | — | Food and Beverage | In-kind items and services | $152.87 | General |
| 08/07/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/02/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $31.13 | General |
| Category: IMMUNOLOGY | ||||||
| 07/05/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: Immunology | ||||||
| 06/12/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: Immunology | ||||||
| 05/31/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: Immunology | ||||||
| 05/17/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.98 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/19/2023 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $15.86 | General |
| Category: DERMATOLOGY | ||||||
| 04/06/2023 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: Immunology | ||||||
| 04/03/2023 | Smith+Nephew, Inc. | GRAFIX PL (Medical Supply) | Food and Beverage | In-kind items and services | $26.96 | General |
| Category: Other Advanced Wound Management | ||||||
| 03/08/2023 | Sun Pharmaceutical Industries Inc. | Odomzo (Drug), BLU-U | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: Oncology | ||||||
| 02/14/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.33 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/06/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/01/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: Immunology | ||||||
| 01/16/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.49 | General |
| Category: Immunology | ||||||
| 12/13/2022 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: Immunology | ||||||
| 11/16/2022 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Immunology | ||||||
| 10/06/2022 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: Dermatology | ||||||
| 09/12/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: IMMUNOLOGY | ||||||
| 06/27/2022 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 1,465 | 4,408 | $1.4M | $352,075 |
| 2022 | 23 | 1,192 | 1,393 | $1.3M | $321,638 |
| 2021 | 15 | 675 | 809 | $893,258 | $226,537 |
| 2020 | 19 | 790 | 885 | $946,265 | $233,791 |
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 282 | 357 | $615,989 | $172,193 | 28.0% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 84 | 101 | $163,611 | $45,369 | 27.7% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 93 | 115 | $120,582 | $37,211 | 30.9% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 122 | 126 | $99,582 | $20,170 | 20.3% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 90 | 95 | $77,153 | $11,932 | 15.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 159 | 175 | $40,250 | $10,920 | 27.1% |
| 12051 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.5 cm or less | Office | 2023 | 52 | 54 | $39,428 | $6,073 | 15.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 56 | 57 | $18,810 | $5,270 | 28.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 67 | 74 | $19,688 | $4,348 | 22.1% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 25 | 27 | $19,455 | $3,611 | 18.6% |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 2023 | 12 | 2,600 | $10,400 | $3,372 | 32.4% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 23 | 24 | $19,156 | $3,293 | 17.2% |
| 17260 | Destruction of cancer skin growth of trunk, arms, or legs, 0.5 cm or less | Office | 2023 | 41 | 58 | $14,673 | $3,146 | 21.4% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 30 | 31 | $19,660 | $3,125 | 15.9% |
| 12031 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | Office | 2023 | 23 | 23 | $15,629 | $2,902 | 18.6% |
| 17270 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less | Office | 2023 | 23 | 29 | $11,106 | $2,464 | 22.2% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 21 | 24 | $10,950 | $2,458 | 22.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 25 | 26 | $7,553 | $2,212 | 29.3% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 14 | 17 | $8,957 | $2,183 | 24.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 53 | 56 | $9,428 | $2,128 | 22.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 19 | 19 | $5,415 | $1,482 | 27.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 32 | 33 | $4,785 | $1,413 | 29.5% |
| 12041 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.5 cm or less | Office | 2023 | 11 | 11 | $7,504 | $1,249 | 16.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 22 | 32 | $4,327 | $1,226 | 28.3% |
| 17280 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2023 | 13 | 14 | $5,044 | $936.81 | 18.6% |
About Dr. William Lear, MD
Dr. William Lear, MD is a Dermatology healthcare provider based in Salem, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/16/2007. The National Provider Identifier (NPI) number assigned to this provider is 1558553115.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Lear, MD has received a total of $1,174 in payments from pharmaceutical and medical device companies, with $90.42 received in 2024. These payments were reported across 45 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,174).
As a Medicare-enrolled provider, Lear has provided services to 4,122 Medicare beneficiaries, totaling 7,495 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Other Specialties MOHS-Micrographic Surgery
- Location Salem, OR
- Active Since 08/16/2007
- Last Updated 07/17/2015
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1558553115
Products in Payments
- DUPIXENT (Biological) $134.34
- TREMFYA (Drug) $125.46
- GRAFIX/GRAFIXPL/STRAVIX (Biological) $118.07
- TALTZ (Drug) $116.43
- COSENTYX (Biological) $95.14
- LIBTAYO (Biological) $38.56
- SPEVIGO (Drug) $31.13
- Erivedge (Biological) $30.88
- OPZELURA (Drug) $27.31
- GRAFIX PL (Medical Supply) $26.96
- REMICADE (Biological) $22.25
- OLUMIANT (Drug) $21.67
- ENSTILAR (Drug) $21.05
- ILUMYA (Biological) $20.34
- Sotyktu (Drug) $17.49
- SKYRIZI (Biological) $17.11
- Odomzo (Drug) $15.93
- AMELUZ (Drug) $15.86
- Humira (Biological) $15.66
- ClosureFast (Device) $14.93
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Salem
Dr. Russell Young, Md, MD
Dermatology — Payments: $10,674
Gary Gross, M.d, M.D
Dermatology — Payments: $10,537
Lacey Roybal, D.o, D.O
Dermatology — Payments: $7,933
Paarth Dodia, Do, DO
Dermatology — Payments: $7,518
Dr. Patrick Whitman, Do, DO
Dermatology — Payments: $7,329
Dr. Preston Chadwick, M.d, M.D
Dermatology — Payments: $6,596